Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

477
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
477

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Special Issue, Part II</i> 20th International Symposium on Bioinformatics Research and Applications (ISBRA 2024).

Journal of computational biology : a journal of computational molecular cell biology·2025
Same author

<i>Special Issue, Part I</i> 20th International Symposium on Bioinformatics Research and Applications (ISBRA 2024).

Journal of computational biology : a journal of computational molecular cell biology·2025
Same author

Integrating Time and Frequency Domain Features of fMRI Time Series for Alzheimer's Disease Classification Using Graph Neural Networks.

Interdisciplinary sciences, computational life sciences·2025
Same author

Supervised graph contrastive learning for cancer subtype identification through multi-omics data integration.

Health information science and systems·2024
Same author

MHCLMDA: multihypergraph contrastive learning for miRNA-disease association prediction.

Briefings in bioinformatics·2024
Same author

MiRNA-gene network embedding for predicting cancer driver genes.

Briefings in functional genomics·2023

Related Experiment Video

Updated: Oct 6, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.4K

Identifying Cancer Subtypes Using a Residual Graph Convolution Model on a Sample Similarity Network.

Wei Dai1, Wenhao Yue1, Wei Peng1,2

  • 1Faculty of Information Engineering and Automation, Kunming University of Science and Technology, Kunming 650050, China.

Genes
|January 21, 2022
PubMed
Summary

This study introduces a novel cancer subtype classification method using a graph convolutional network (GCN) and sample similarity network, improving accuracy and identifying key genes for targeted therapies.

Keywords:
cancer subtype classificationdeep learningresidual graph convolutional networksample interaction

More Related Videos

Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps
08:59

Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps

Published on: October 28, 2018

7.2K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

239

Related Experiment Videos

Last Updated: Oct 6, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

7.4K
Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps
08:59

Morphology-Based Distinction Between Healthy and Pathological Cells Utilizing Fourier Transforms and Self-Organizing Maps

Published on: October 28, 2018

7.2K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

239

Area of Science:

  • Oncology
  • Bioinformatics
  • Computational Biology

Background:

  • Cancer subtype classification is crucial for understanding disease mechanisms and developing targeted therapies.
  • Previous methods often overlook the interconnectedness of cancer samples, limiting subtype identification.
  • Inter-sample relationships, particularly gene co-expression patterns, can provide valuable insights into cancer heterogeneity.

Purpose of the Study:

  • To develop an advanced cancer subtype classification method that leverages sample interactions.
  • To improve the accuracy and clinical relevance of cancer subtyping.
  • To identify essential genes and biological pathways associated with identified cancer subtypes.

Main Methods:

  • A sample similarity network was constructed based on cancer gene co-expression patterns.
  • A two-layer graph convolutional network (GCN) model integrated gene expression profiles and the sample similarity network.
  • Initial features were incorporated into the GCN to mitigate over-smoothing, followed by softmax classification.

Main Results:

  • The proposed model achieved high accuracy in classifying subtypes for breast invasive carcinoma (BRCA, 82.58%), glioblastoma multiforme (GBM, 85.13%), and lung cancer (LUNG, 79.18%).
  • Performance surpassed existing cancer subtype classification methods.
  • Survival analysis confirmed the clinical significance of the identified subtypes.

Conclusions:

  • The developed GCN-based method effectively classifies cancer subtypes by considering sample similarities and gene expression.
  • The model's ability to identify essential genes and pathways offers potential for novel therapeutic strategies.
  • This approach enhances our understanding of cancer pathogenesis and facilitates personalized treatment strategies.